CN101190322B - Traditional Chinese medicine for treating zoster post herpetic neuralgia - Google Patents

Traditional Chinese medicine for treating zoster post herpetic neuralgia Download PDF

Info

Publication number
CN101190322B
CN101190322B CN200610131664A CN200610131664A CN101190322B CN 101190322 B CN101190322 B CN 101190322B CN 200610131664 A CN200610131664 A CN 200610131664A CN 200610131664 A CN200610131664 A CN 200610131664A CN 101190322 B CN101190322 B CN 101190322B
Authority
CN
China
Prior art keywords
radix
herpetic neuralgia
chinese medicine
medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200610131664A
Other languages
Chinese (zh)
Other versions
CN101190322A (en
Inventor
李洋
李有田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200610131664A priority Critical patent/CN101190322B/en
Publication of CN101190322A publication Critical patent/CN101190322A/en
Application granted granted Critical
Publication of CN101190322B publication Critical patent/CN101190322B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese traditional medicine used for treating postherpetic neuralgia, which aims at developing a Chinese traditional medicine used for treating postherpetic neuralgia by adopting the theory of Chinese traditional medicine. The formula of the invention includes magnet, turmeric, dyers woad leaf, radix isatidis, cape jasmine fruit, radix scutellariae, Chinese thorowax root, rehmanniae praeparatum, semen plantaginis, liquoric root, angelica and white paeony root. The invention has the advantages of low price, good curative effect, being not easy to recur and extremelygood social and economic benefits. The total effective rate of the medicine of the invention can reach more than 94.70%.

Description

A kind of Chinese medicine for the treatment of post-herpetic neuralgia
Technical field:
The invention belongs to the field of Chinese medicines, particularly relate to a kind of Chinese medicine for the treatment of post-herpetic neuralgia.
Background technology
Post-herpetic neuralgia is commonly encountered diseases, the frequently-occurring disease of department of dermatologry and the department of neurology and the department of Chinese medicine, and it is funny by water---herpesvirus causes.Because the primary disease toxin can be hidden in dorsal ganglion for a long time, so still left over neuralgia after the herpes incrustation, some even delay difficulty are more given patient's life, study, work and are brought greatly painful mentally.At present, this disease still there is not specific treatment both at home and abroad.America and Europe and Japan and other countries are to the treatment of post-herpetic neuralgia, adopt cut off root of sympathetic nerve more, ethanol sealing or with treatments such as hormone, vitamin B group, analgesics, though pain is alleviated, but side effect is many, and cost an arm and a leg, treatment time longer relapse rate height and patient nearly shortcoming such as should not accept.
Summary of the invention:
The objective of the invention is to adopt theory of Chinese medical science, develop a kind of Chinese medicine for the treatment of post-herpetic neuralgia.
The present invention makes the raw materials of effective components weight portion and consists of:
Magnetitum 8~15 Radix Curcumaes 1~2 Folium Isatidis 5~10
Radix Isatidis 5~10 Fructus Gardeniaes 1~1.5 Radix Scutellariae 1.5~2.5
Radix Bupleuri 1~1.5 Radix Rehmanniae 1.5~2.5 Semen Plantaginiss 1~2
Radix Glycyrrhizae 0.5~1.5 Radix Angelicae Sinensis 1.5~2 Radix Paeoniae Albas 1.5~3
The present invention is cheap, good effect, and treatment time is short, should not recur, and social benefit, economic benefit are splendid.Medicine total effective rate of the present invention reaches more than 94.70%.
The specific embodiment:
The present invention makes the raw materials of effective components weight portion and consists of:
Magnetitum 8~15 Radix Curcumaes 1~2 Folium Isatidis 5~10
Radix Isatidis 5~10 Fructus Gardeniaes 1~1.5 Radix Scutellariae 1.5~2.5
Radix Bupleuri 1~1.5 Radix Rehmanniae 1.5~2.5 Semen Plantaginiss 1~2
Radix Glycyrrhizae 0.5~1.5 Radix Angelicae Sinensis 1.5~2 Radix Paeoniae Albas 1.5~3
Preparation method is:
1. said medicine is placed one and reinstate cold water immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. press secondary every day, each 200ml one after each meal.
Embodiment 1:
Magnetitum 8 Radix Curcumaes 1 Folium Isatidis 5
Radix Isatidis 5 Fructus Gardeniaes 1 Radix Scutellariae 1.5
Radix Bupleuri 1 Radix Rehmanniae 1.5 Semen Plantaginiss 1
Radix Glycyrrhizae 0.5 Radix Angelicae Sinensis 1.5 Radix Paeoniae Albas 1.5
Preparation method is:
1. said medicine is placed one and reinstate cold water 500ml immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead, medicinal liquid is surplus to be 100ml;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. every part of 100ml, every day secondary, each 100ml one after each meal.
Embodiment 2:
Magnetitum 11.5 Radix Curcumaes 1.5 Folium Isatidiss 7.5
Radix Isatidis 7.5 Fructus Gardeniaes 1.25 Radix Scutellariaes 2
Radix Bupleuri 1.25 Radix Rehmanniae 2 Semen Plantaginiss 1.5
Radix Glycyrrhizae 1 Radix Angelicae Sinensis 1.75 Radix Paeoniae Albas 2.25
Preparation method is:
1. said medicine is placed one and reinstate cold water 1000ml immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead, medicinal liquid is surplus to be 200ml;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. every part of 200ml, every day secondary, each 200ml one after each meal.
Embodiment 3:
Magnetitum 15 Radix Curcumaes 2 Folium Isatidiss 10
Radix Isatidis 10 Fructus Gardeniaes 1.5 Radix Scutellariaes 2.5
Radix Bupleuri 1.5 Radix Rehmanniae 2.5 Semen Plantaginiss 2
Radix Glycyrrhizae 1.5 Radix Angelicae Sinensis 2 Radix Paeoniae Albas 3
Preparation method is:
1. said medicine is placed one and reinstate cold water 1500ml immersion 30 minutes;
2. boiled 30 minutes with big fire;
3. use slow fire boiling instead, medicinal liquid is surplus to be 200ml;
4. use health gauze three layer filtration;
5. repeat above-mentioned steps, the herb liquid of obtaining for twice is placed in one glass, divide two parts;
6. every part of 200ml, every day secondary, each 200ml one after each meal.
Clinical experiment of the present invention:
Drug therapy herpes neuralgia 315 examples of the present invention, matched group somedon treatment herpes neuralgia 79 examples, all cases all are diagnosed as the out-patient of post-herpetic neuralgia through No.1 Hospital of Jilin Univ.'s department of dermatologry or Neurology Department.
According to document post herpetic neuralgia is divided into III degree (Huang Yanshou chief editor, pain, Xi'an: People's Education Publishing House, Shaanxi, 1993.74): slight (+): patient tells pain, does not influence rest, no attitude movement response; Moderate (++): it is obvious that patient tells pain, but can stand, and no attitude movement response is had a rest in influence slightly; Severe (+++): patient tells sharp ache, is difficult to tolerance, and influence is had a rest, and can not fall asleep, and action (affected part nude) occurs escaping.
2 groups of patients' general clinical data and state of an illness contrast see Table 1:
Table 1:
Figure G2006101316647D00041
Figure G2006101316647D00051
Tcm syndrome differentiation and typing (Cheng Shiqi chief editor, Chinese medicine. Beijing: People's Health Publisher, 1994.178) 1. liver and gall fire Sheng type (or claiming excessive heat type, fire-toxin type): Pi Fu inflammation is red, as seen the vesicle of pimple and tonic vesicle wall, conscious scorching hot severe pain, companion's dry throat with bitter taste, the yellow urine constipation, red tongue, yellow fur, wiry and frequent pulse.2. spleen and stomach damp-heat type (damp-heat type, noxious dampness type): the patient has tangible pale vesicle, collection bunch in groups, bleb liquid muddiness, diabrosis is oozed out or is rotten to the corn, companion's pain, indigestion and loss of appetite abdominal distention, pale tongue, tongue is greasy in vain or yellow greasy, soft and rapid pulse or sliding number.3. qi stagnation and blood stasis type: deflorescence, but still gnawing pains take no rest, and it is not peaceful to sleep night, and body of the tongue is dark violet, white and thin fur, thready and stringy pulse.Treatment is organized in 315 examples, liver and gall fire Sheng type 203 examples, spleen and stomach damp-heat type 7 examples, qi stagnation and blood stasis type 105 examples.
Medicine and Therapeutic Method:
Treatment group decoct 200ml of the present invention, 2 times on the 1st, make every 200ml by the Drug Manufacturing Room of No.1 Hospital of Jilin Univ. by prescription of the present invention and contain 11.5 parts of Magnetitums, 1.5 parts of Radix Curcumaes, 7.5 parts of Folium Isatidiss, 7.5 parts of Radix Isatidiss, 1.25 parts of Fructus Gardeniaes, 2 parts of Radix Scutellariaes, 1.25 parts of Radix Bupleuri, 2 parts in the Radix Rehmanniae, 1.5 parts of Semen Plantaginiss, 1 part in Radix Glycyrrhizae, 1.75 parts of Radix Angelicae Sinensis, 2.25 parts of the Radix Paeoniae Albas.The oral somedon 0.5g of matched group (Ji Rui pharmaceutcal corporation, Ltd in Changchun produces, the date of manufacture: on November 8th, 1996), each 1,2 times on the 1st.Two groups was 1 course of treatment with 10 days all, the period in a medicine other drug of stopping using.
The result:
Criterion of therapeutical effect is cured: affected part post herpetic neuralgia symptom complete obiteration, after clinical observation half a year, there is not the recidivist.Take a turn for the better: affected part post herpetic neuralgia sx, intermittently prolong, the recidivist appears again after discontinuing medication.Invalid: through 3 more than the course of treatment treatment after, the post herpetic neuralgia symptom does not have the improver.
2 groups of efficacy results see Table 2, table 3
Table 2:
Figure G2006101316647D00061
Table 3:
Figure G2006101316647D00062
Treatment group curative effect and tcm syndrome differentiation and typing curative effect with liver and gall fire Sheng type and qi stagnation and blood stasis type for well.Liver and gall fire Sheng type is totally 203 examples, wherein cures 153 examples, accounts for 75.4%, and 45 examples that take a turn for the better account for 22.1%; Qi stagnation and blood stasis type is totally 105 examples, wherein cures 69 examples, accounts for 65.7%, and 32 examples that take a turn for the better account for 30.5%.
After half a year, follow up a case by regular visits to curing case, the treatment group is followed up a case by regular visits to 223 examples, recurrence 8 examples (accounting for 3.6%) after the drug withdrawal; Matched group is followed up a case by regular visits to recurrence 11 examples (accounting for 68.8%) in 16 examples, and relapse rate is with of the present invention group obviously low (P<0.01).In addition, the matched group period in a medicine has 9 examples vomiting to occur, and erythra appears in 4 examples, amount to 13 examples (accounting for 16.5%), and the treatment group is not seen and other untoward reaction similar.
Discuss and cognition:
Motherland's medical science is thought: primary disease is many because of due to the factor affecting hepatobiliary catharsis functions such as gas, blood, wet, heat.315 routine post-herpetic neuralgia patients of clinical research of the present invention, for seeing, and spleen and stomach damp-heat type is more rare more with liver and gall fire Sheng type and qi stagnation and blood stasis type for differential diagnosis in tcm.Think that post herpetic neuralgia is that liver and gall fire is contained, due to waste heat (poison) is clear, so the present invention adopts the liver heat removing function of gallbladder promoting, eliminating fire and detoxication, removing waste heat (poison), blood circulation promoting and blood stasis dispelling, dredge the meridian passage, promoting the circulation of QI to relieve pain, general rule are bitterly method not.Magnetitum, Radix Curcumae, Folium Isatidis are monarch drug in the prescription, and Radix Isatidis, Fructus Gardeniae, Radix Scutellariae are ministerial drug, and Radix Bupleuri, the Radix Rehmanniae, Semen Plantaginis are adjuvant drug, and Radix Glycyrrhizae, Radix Angelicae Sinensis, the Radix Paeoniae Alba are messenger drug.All medicines share, and play removing fire from the liver altogether, dampness removing heat, and yin nourishing blood, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is removed waste heat (poison), to reach not bitterly merit of general rule.
Also finding in the treatment, take medicine of the present invention, can obviously shorten the course of treatment, is excellent than traditional western medicine, and medicine source abundance, and inexpensive, taking convenience is not seen toxic and side effects, is the comparatively ideal medicine of treatment primary disease.

Claims (1)

1. Chinese medicine for the treatment of post-herpetic neuralgia, wherein make the raw materials of effective components weight portion and consist of:
Magnetitum 8~15 Radix Curcumaes 1~2 Folium Isatidis 5~10
Radix Isatidis 5~10 Fructus Gardeniaes 1~1.5 Radix Scutellariae 1.5~2.5
Radix Bupleuri 1~1.5 Radix Rehmanniae 1.5~2.5 Semen Plantaginiss 1~2
Radix Glycyrrhizae 0.5~1.5 Radix Angelicae Sinensis 1.5~2 Radix Paeoniae Albas 1.5~3.
CN200610131664A 2006-11-24 2006-11-24 Traditional Chinese medicine for treating zoster post herpetic neuralgia Expired - Fee Related CN101190322B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200610131664A CN101190322B (en) 2006-11-24 2006-11-24 Traditional Chinese medicine for treating zoster post herpetic neuralgia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200610131664A CN101190322B (en) 2006-11-24 2006-11-24 Traditional Chinese medicine for treating zoster post herpetic neuralgia

Publications (2)

Publication Number Publication Date
CN101190322A CN101190322A (en) 2008-06-04
CN101190322B true CN101190322B (en) 2010-05-26

Family

ID=39485618

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200610131664A Expired - Fee Related CN101190322B (en) 2006-11-24 2006-11-24 Traditional Chinese medicine for treating zoster post herpetic neuralgia

Country Status (1)

Country Link
CN (1) CN101190322B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101306186B (en) * 2008-06-10 2011-09-21 叶明伟 Traditional Chinese medicine taken orally for treating Qi stagnation and blood stasis type zoster
CN102379957A (en) * 2010-09-03 2012-03-21 北京以岭药业有限公司 TCM composition applied to preparation of medication for treating herpes zoster
CN103385937B (en) * 2013-07-26 2014-11-19 广东省中医药工程技术研究院 Traditional Chinese medicine preparation for preventing and treating herpes zoster and postherpetic neuralgia and preparation method thereof
CN106138251A (en) * 2016-08-25 2016-11-23 颜喜贤 A kind of Chinese medicine composition treating herpes zoster
CN106511890A (en) * 2016-10-27 2017-03-22 谭奇纹 Traditional Chinese medicine used for treating postherpetic neuralgia

Also Published As

Publication number Publication date
CN101190322A (en) 2008-06-04

Similar Documents

Publication Publication Date Title
CN102233085A (en) External application drug for treating skin diseases
CN102908386A (en) Traditional Chinese medicine for treating kidney stone
CN101190322B (en) Traditional Chinese medicine for treating zoster post herpetic neuralgia
CN102688420B (en) Traditional Chinese medicine decoction for treating psoriasis
CN102078462A (en) Asthma relieving medicament
CN101062198A (en) Decoction for treating arthritis
CN101152354A (en) Traditional Chinese medicine for treating acute dacryocystitis
CN102579838B (en) Chinese medicine composition for curing synovitis and preparation method thereof
CN102349980B (en) Traditional Chinese medicine for treating rheumatism
CN104587299A (en) Traditional Chinese medicine preparation for treating gastric and duodenal ulcers
CN101152343A (en) Traditional Chinese medicine for treating chronic dacryocystitis
CN101152313A (en) Traditional Chinese medicine for treating summer dermatitis
CN103550446B (en) Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition
CN1965945A (en) Tincture having ageratum and mint for treating heat rash
CN104288385A (en) Drug addiction treatment traditional Chinese medicine
CN1180800C (en) A Chinese medicinal composition for treating diseases of kidney and urinary system
CN103690654A (en) Pharmaceutical composition for treating infantile diarrhea
CN102626479B (en) External-use Chinese herbal medicine composition for chronic rheumatism treatment
CN101288760B (en) Externally-used drug for treating appendicitis
CN1168464C (en) Hepatosis treating traditional Chinese medicine
CN101129965A (en) Traditional Chinese medicine for treating chronic schistosomiasis diarrhea
CN101152362A (en) Traditional Chinese medicine for treating epidemic parotitis
CN104800315A (en) Traditional Chinese medicine for treating pelvic floor muscle cramp syndrome
CN101167983A (en) Traditional Chinese medicine for treating dacryocystitis with hidden eyes
CN101167916A (en) Traditional Chinese medicine for treating chronic nasosinusitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100526

Termination date: 20111124